ProCE Banner Activity

Dr. Joseph Eron and Dr. Babafemi Taiwo: Key HIV Studies from CROI 2023


Hear from CCO’s expert faculty members as they present their insights on some of the most clinically relevant new data presented at CROI 2023, including prevention strategies, long-acting therapies, adverse events, second-line therapies, and coinfection.

Released: March 17, 2023

Expiration: March 15, 2024

No longer available for credit.



Joseph J. Eron, Jr.

Joseph J. Eron, Jr., MD

Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology
Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Babafemi Taiwo

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Chicago, Illinois


Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Joseph J. Eron, Jr., MD: consultant/advisor/speaker: Gilead Sciences, GlaxoSmithKline, Janssen, Merck, ViiV; researcher: Gilead Sciences, ViiV.

Babafemi Taiwo, MBBS: advisor: Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, ViiV Healthcare.